Sitrin Capital Management LLC Gilead Sciences, Inc. Transaction History

Sitrin Capital Management LLC

  • $200 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020
SELL
$62.1 - $78.08 $4.49 Million - $5.65 Million
-72,303 Closed
0 $0
Q2 2020

Aug 06, 2020
SELL
$72.34 - $84.0 $473,827 - $550,200
-6,550 Reduced 8.31%
72,303 $5.56 Million
Q1 2020

May 11, 2020
BUY
$62.63 - $80.22 $4.94 Million - $6.33 Million
78,853 New
78,853 $5.9 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sitrin Capital Management LLC Portfolio

Follow Sitrin Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sitrin Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sitrin Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email